Bio-Works Technologies AB (publ) (BIOWKS.ST)
Stockholm · SEK · Healthcare · Medical Instruments & Supplies
SEK 3.06 (-7.27%) as of
Key statistics
- Market cap
- 307.27M
- P/E (TTM)
- 306.00
- Forward P/E
- 5.02
- EPS (TTM)
- 0.0100
- Dividend yield
- 0.00%
- 52-week range
- 2.1300 – 4.9800
- Beta
- 0.68
- Revenue (TTM)
- 89.71M
- Profit margin
- 2.46%
- Volume
- 127.71k
About Bio-Works Technologies AB (publ)
Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chromatography (IMAC) resin, size exclusion chromatography (SEC) resins, HTPD formats, screening kits, and desalting columns; and WorkBeads chromatography resins. Its products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications. Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- Uppsala, Sweden
- Employees
- 32
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.